1. Yin, Xinzhen, Wang, Huiying, Wu, Dingwen, Shao, Jingxin, Dai, Yu. 2012. SLC34A2 Gene mutation of pulmonary alveolar microlithiasis: report of four cases and review of literatures. In Respiratory medicine, 107, 217-22. doi:10.1016/j.rmed.2012.10.016. https://pubmed.ncbi.nlm.nih.gov/23164546/
2. Felicio, Paula S, Grasel, Rebeca S, Campacci, Natalia, Carraro, Dirce M, Palmero, Edenir I. 2020. Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer. In Human mutation, 42, 290-299. doi:10.1002/humu.24158. https://pubmed.ncbi.nlm.nih.gov/33326660/
3. Jönsson, Åsa Lina M, Hilberg, Ole, Bendstrup, Elisabeth M, Mogensen, Susie, Simonsen, Ulf. . SLC34A2 gene mutation may explain comorbidity of pulmonary alveolar microlithiasis and aortic valve sclerosis. In American journal of respiratory and critical care medicine, 185, 464. doi:. https://pubmed.ncbi.nlm.nih.gov/22336687/
4. Liu, Xiaozhou, Zhou, Xing, Xu, Haidong, Shi, Xin, Wu, Sujia. 2017. SLC34A2 Regulates the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells Through PTEN/PI3K/AKT Signaling. In DNA and cell biology, 36, 775-780. doi:10.1089/dna.2017.3750. https://pubmed.ncbi.nlm.nih.gov/28777670/